145 related articles for article (PubMed ID: 27388811)
21. Iodinated chlorin p
Sarbadhikary P; Dube A
Chem Biol Interact; 2017 Nov; 277():137-144. PubMed ID: 28918125
[TBL] [Abstract][Full Text] [Related]
22. Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor.
Leung AWY; Anantha M; Dragowska WH; Wehbe M; Bally MB
J Control Release; 2018 Sep; 286():1-9. PubMed ID: 30016731
[TBL] [Abstract][Full Text] [Related]
23. New water-soluble copper (II) complexes including 4,7-dimethyl-1,10-phenanthroline and L-tyrosine: synthesis, characterization, DNA interactions and cytotoxicities.
İnci D; Aydın R; Yılmaz D; Gençkal HM; Vatan Ö; Çinkılıç N; Zorlu Y
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():761-70. PubMed ID: 25448975
[TBL] [Abstract][Full Text] [Related]
24. Gold(III) compounds-mediated inhibition of lung cancer cell proliferation.
Bostancioğlu RB; Kaya M; Koparal AT; Benkli K
Anticancer Drugs; 2016 Mar; 27(3):225-34. PubMed ID: 26825752
[TBL] [Abstract][Full Text] [Related]
25. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
[TBL] [Abstract][Full Text] [Related]
26. In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines.
Dhivya R; Jaividhya P; Riyasdeen A; Palaniandavar M; Mathan G; Akbarsha MA
Biometals; 2015 Oct; 28(5):929-43. PubMed ID: 26335033
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
Adhami F; Safavi M; Ehsani M; Ardestani SK; Emmerling F; Simyari F
Dalton Trans; 2014 Jun; 43(21):7945-57. PubMed ID: 24715093
[TBL] [Abstract][Full Text] [Related]
28. Targeting triple negative breast cancer cells by N3-substituted 9,10-phenanthrenequinone thiosemicarbazones and their metal complexes.
Afrasiabi Z; Stovall P; Finley K; Choudhury A; Barnes C; Ahmad A; Sarkar F; Vyas A; Padhye S
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():114-9. PubMed ID: 23770498
[TBL] [Abstract][Full Text] [Related]
29. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment.
Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT
Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348
[TBL] [Abstract][Full Text] [Related]
30. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
31. [1,10-phenantroline europium complexes: their inclusion in liposomes and cytotoxicity].
Boldyrev IA; Gaenko GP; Moiseeva EV; Deligeorgiev T; Kaloianova S; Lesev N; Vasilev A; Molotkovskiĭ IuG
Bioorg Khim; 2011; 37(3):408-13. PubMed ID: 21899057
[TBL] [Abstract][Full Text] [Related]
32. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
33. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Muenzner JK; Biersack B; Kalie H; Andronache IC; Kaps L; Schuppan D; Sasse F; Schobert R
ChemMedChem; 2014 Jun; 9(6):1195-204. PubMed ID: 24648184
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
[TBL] [Abstract][Full Text] [Related]
35. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
[TBL] [Abstract][Full Text] [Related]
36. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
37. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
[TBL] [Abstract][Full Text] [Related]
38. Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro.
Elo H
Chemotherapy; 2004 Nov; 50(5):229-33. PubMed ID: 15528888
[TBL] [Abstract][Full Text] [Related]
39. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells.
Roseanu A; Florian PE; Moisei M; Sima LE; Evans RW; Trif M
Biometals; 2010 Jun; 23(3):485-92. PubMed ID: 20191307
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, nucleic acid binding and cytotoxicity of polyethyleneimine-copper(II) complexes containing 1,10-phenanthroline and l-valine.
Lakshmipraba J; Arunachalam S; Gandi DA; Thirunalasundari T
Eur J Med Chem; 2011 Jul; 46(7):3013-21. PubMed ID: 21546134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
